Identification of CD161 expression as a novel prognostic biomarker in breast cancer correlated with immune infiltration

Background: CD161 has been identified as a prognostic biomarker in many neoplasms, but its role in breast cancer (BC) has not been fully explained. We aimed to investigate the molecular mechanism and prognostic value of CD161 in BC. Methods: CD161 expression profile was extracted from TIMER, Oncomin...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Miaomiao, Xie, Hui, Zheng, Mingjie, Hou, Xinwen, Wang, Shui, Huang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561259/
https://www.ncbi.nlm.nih.gov/pubmed/36246587
http://dx.doi.org/10.3389/fgene.2022.996345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561259/
https://www.ncbi.nlm.nih.gov/pubmed/36246587
http://dx.doi.org/10.3389/fgene.2022.996345

Ejemplares similares